Callan Family Office’s Nomura Holdings NMR Stock Holding History
Bought
Maintained
Sold
Other funds holding NMR
DSC
QCM
Callan Family Office's NMR Position: Q1 2026 in Review
Callan Family Office reduced its Nomura Holdings (NMR) stake by 0.42% in Q1 2026, selling an estimated $6.01K and leaving 166,576 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #485.
Callan Family Office first reported a position in NMR in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.4M in Q4 2025. 271 funds tracked by Wall St. Rank hold NMR as of Q1 2026.
- Callan Family Office held 166,576 shares of Nomura Holdings worth $1.31M as of Q1 2026.
- Callan Family Office sold 698 Nomura Holdings shares in Q1 2026, an estimated $6.01K.
- Nomura Holdings made up 0.03% of Callan Family Office's portfolio in Q1 2026, its #485 holding.
- Callan Family Office first reported a position in Nomura Holdings in Q4 2024 and has held it in 6 quarters since.
- Callan Family Office's Nomura Holdings position peaked at $1.4M in Q4 2025.
- 271 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.